MCL coexpression mm9:403
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr12:45540065..45540076,+ | p9@Nrcam |
Mm9::chr13:54431398..54431402,+ | p@chr13:54431398..54431402 + |
Mm9::chr13:54467800..54467801,+ | p@chr13:54467800..54467801 + |
Mm9::chr14:122874424..122874441,- | p1@2610035F20Rik |
Mm9::chr14:65208698..65208735,+ | p3@ENSMUST00000164162 |
Mm9::chr16:16560211..16560238,- | p6@Fgd4 |
Mm9::chr16:16560239..16560290,- | p3@Fgd4 |
Mm9::chr16:16560294..16560316,- | p4@Fgd4 |
Mm9::chr17:26088998..26089027,- | p1@ENSMUST00000162431 p1@uc008bcv.1 |
Mm9::chr2:105514700..105514715,+ | p13@Pax6 |
Mm9::chr2:79231715..79231718,- | p6@Cerkl |
Mm9::chr2:79292080..79292119,- | p@chr2:79292080..79292119 - |
Mm9::chr2:79294073..79294117,- | p@chr2:79294073..79294117 - |
Mm9::chr2:79294856..79294867,- | p@chr2:79294856..79294867 - |
Mm9::chr2:79295107..79295119,- | p@chr2:79295107..79295119 - |
Mm9::chr2:79296458..79296461,- | p@chr2:79296458..79296461 - |
Mm9::chr2:79296783..79296801,- | p1@Neurod1 |
Mm9::chr2:79296907..79296918,- | p2@Neurod1 |
Mm9::chr6:104443214..104443224,+ | p10@Cntn6 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0007417 | central nervous system development | 0.00179441931292426 |
GO:0032990 | cell part morphogenesis | 0.00179441931292426 |
GO:0048858 | cell projection morphogenesis | 0.00179441931292426 |
GO:0030030 | cell projection organization and biogenesis | 0.00179441931292426 |
GO:0000902 | cell morphogenesis | 0.00543333884663067 |
GO:0032989 | cellular structure morphogenesis | 0.00543333884663067 |
GO:0043010 | camera-type eye development | 0.00543333884663067 |
GO:0007411 | axon guidance | 0.00543333884663067 |
GO:0009952 | anterior/posterior pattern formation | 0.00579654942489049 |
GO:0021902 | commitment of a neuronal cell to a specific type of neuron in the forebrain | 0.00579654942489049 |
GO:0021877 | forebrain neuron fate commitment | 0.00579654942489049 |
GO:0045165 | cell fate commitment | 0.00579654942489049 |
GO:0001654 | eye development | 0.00579654942489049 |
GO:0007399 | nervous system development | 0.00621337240759742 |
GO:0048856 | anatomical structure development | 0.00854992126284358 |
GO:0003002 | regionalization | 0.00939158937203724 |
GO:0007409 | axonogenesis | 0.00969655818258358 |
GO:0048667 | neuron morphogenesis during differentiation | 0.00971344345791167 |
GO:0048812 | neurite morphogenesis | 0.00971344345791167 |
GO:0019227 | action potential propagation | 0.00973599120688521 |
GO:0007420 | brain development | 0.00995764535848094 |
GO:0000904 | cellular morphogenesis during differentiation | 0.00995764535848094 |
GO:0007423 | sensory organ development | 0.00995764535848094 |
GO:0009950 | dorsal/ventral axis specification | 0.00995764535848094 |
GO:0021798 | forebrain dorsal/ventral pattern formation | 0.00995764535848094 |
GO:0031175 | neurite development | 0.00995764535848094 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 0.00995764535848094 |
GO:0005515 | protein binding | 0.0100964278780441 |
GO:0048666 | neuron development | 0.0113321223092617 |
GO:0007389 | pattern specification process | 0.0114503423936315 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 0.0114503423936315 |
GO:0022612 | gland morphogenesis | 0.0114503423936315 |
GO:0021871 | forebrain regionalization | 0.0114503423936315 |
GO:0007435 | salivary gland morphogenesis | 0.0114503423936315 |
GO:0021879 | forebrain neuron differentiation | 0.0129756327257196 |
GO:0009653 | anatomical structure morphogenesis | 0.0134212707117066 |
GO:0016477 | cell migration | 0.0135297673807931 |
GO:0021872 | generation of neurons in the forebrain | 0.0135297673807931 |
GO:0030182 | neuron differentiation | 0.0135297673807931 |
GO:0045941 | positive regulation of transcription | 0.0135699617528827 |
GO:0045935 | positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0137588549566502 |
GO:0032502 | developmental process | 0.0137588549566502 |
GO:0030035 | microspike biogenesis | 0.0147401905676848 |
GO:0007257 | activation of JNK activity | 0.0147401905676848 |
GO:0048699 | generation of neurons | 0.0149698395928933 |
GO:0043507 | positive regulation of JNK activity | 0.0149698395928933 |
GO:0006928 | cell motility | 0.0149698395928933 |
GO:0051674 | localization of cell | 0.0149698395928933 |
GO:0007431 | salivary gland development | 0.0156176295143254 |
GO:0022008 | neurogenesis | 0.0156176295143254 |
GO:0031325 | positive regulation of cellular metabolic process | 0.0161895943822009 |
GO:0030175 | filopodium | 0.0161895943822009 |
GO:0042995 | cell projection | 0.0161895943822009 |
GO:0021543 | pallium development | 0.0161895943822009 |
GO:0035272 | exocrine system development | 0.0161895943822009 |
GO:0042462 | eye photoreceptor cell development | 0.0161895943822009 |
GO:0009893 | positive regulation of metabolic process | 0.0161895943822009 |
GO:0043506 | regulation of JNK activity | 0.0163791565715026 |
GO:0030032 | lamellipodium biogenesis | 0.0163791565715026 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 0.0163791565715026 |
GO:0045665 | negative regulation of neuron differentiation | 0.0167262475532054 |
GO:0001754 | eye photoreceptor cell differentiation | 0.0167262475532054 |
GO:0009798 | axis specification | 0.0172143878295004 |
GO:0042461 | photoreceptor cell development | 0.0172143878295004 |
GO:0021983 | pituitary gland development | 0.0179446169784669 |
GO:0006366 | transcription from RNA polymerase II promoter | 0.0181984630979 |
GO:0021536 | diencephalon development | 0.0193390463751049 |
GO:0048663 | neuron fate commitment | 0.0197152584466631 |
GO:0046530 | photoreceptor cell differentiation | 0.0197152584466631 |
GO:0048731 | system development | 0.0209800527282815 |
GO:0021537 | telencephalon development | 0.0209800527282815 |
GO:0001709 | cell fate determination | 0.0215107127193711 |
GO:0048869 | cellular developmental process | 0.0215107127193711 |
GO:0030154 | cell differentiation | 0.0215107127193711 |
GO:0045664 | regulation of neuron differentiation | 0.0233050062515438 |
GO:0022610 | biological adhesion | 0.0298487604054241 |
GO:0007155 | cell adhesion | 0.0298487604054241 |
GO:0000187 | activation of MAPK activity | 0.0298487604054241 |
GO:0043406 | positive regulation of MAP kinase activity | 0.0334792427771437 |
GO:0030902 | hindbrain development | 0.0334792427771437 |
GO:0007254 | JNK cascade | 0.0334792427771437 |
GO:0009953 | dorsal/ventral pattern formation | 0.0334792427771437 |
GO:0048592 | eye morphogenesis | 0.0334792427771437 |
GO:0050767 | regulation of neurogenesis | 0.0346117301328483 |
GO:0031098 | stress-activated protein kinase signaling pathway | 0.0349608027389977 |
GO:0030031 | cell projection biogenesis | 0.0355554181013376 |
GO:0035270 | endocrine system development | 0.0355554181013376 |
GO:0007275 | multicellular organismal development | 0.0355554181013376 |
GO:0030027 | lamellipodium | 0.0355554181013376 |
GO:0007219 | Notch signaling pathway | 0.0358739848435849 |
GO:0030334 | regulation of cell migration | 0.0367876692441853 |
GO:0048522 | positive regulation of cellular process | 0.0367876692441853 |
GO:0005089 | Rho guanyl-nucleotide exchange factor activity | 0.0367876692441853 |
GO:0001764 | neuron migration | 0.0377614798551938 |
GO:0035023 | regulation of Rho protein signal transduction | 0.0380391672205281 |
GO:0005088 | Ras guanyl-nucleotide exchange factor activity | 0.039237748839414 |
GO:0051270 | regulation of cell motility | 0.039237748839414 |
GO:0043405 | regulation of MAP kinase activity | 0.0394912962577309 |
GO:0016043 | cellular component organization and biogenesis | 0.0398863744207733 |
GO:0030424 | axon | 0.0399827555688522 |
GO:0040012 | regulation of locomotion | 0.0402209771220318 |
GO:0048518 | positive regulation of biological process | 0.0437803629891882 |
GO:0048732 | gland development | 0.0462705259130253 |
GO:0031252 | leading edge | 0.0470538335527206 |
GO:0007266 | Rho protein signal transduction | 0.0490371344115926 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |